24 February 2025: PIB Summary For UPSC
1. Union Health Ministry takes immediate action in response to concerns on export of unapproved drug combination of Tapentadol and Carisoprodol
(Source – https://pib.gov.in/PressReleasePage.aspx?PRID=2105672 )
| Topic: GS2 – Social justice – Health |
| Context |
|
About Tapentadol and Carisoprodol:
- Tapentadol: It is an opioid analgesic used for treating moderate to severe pain.
- It works by binding to opioid receptors and inhibiting norepinephrine reuptake, providing dual-action pain relief.
- It is available in immediate-release (50, 75, and 100 mg) and extended-release (100, 150, and 200 mg) tablet forms.
- Carisoprodol: It is a centrally acting muscle relaxant used to relieve musculoskeletal pain and discomfort.
- It acts on the brain and spinal cord to suppress nerve signals causing pain.
- The combination of Tapentadol and Carisoprodol is not approved in India due to safety concerns.
Why has the government banned the export?
- Aveo Pharmaceuticals exported these drugs without proper authorization, violating regulatory norms.
- A CDSCO audit revealed non-compliance, leading to a stop activity order and seizure of 1.3 crore tablets.
- The ban ensures public safety, prevents misuse, and upholds pharmaceutical industry standards.
Check Out 22 February 2025: PIB Summary For UPSC
